Skip to main content
. 2021 Jun 3;12:625145. doi: 10.3389/fgene.2021.625145

TABLE 1.

Description of clinic pathologic factors for 285 ovarian cancer patients from TCGA.

Clinic pathologic variable* Dead (N = 115) Alive (N = 170)
Age (years) 63.89 (11.26) 59.03 (10.2)
FIGO Stage
I 1 (0.87) 0 (0.00)
II 2 (1.74) 10 (5.88)
III 88 (76.52) 135 (79.41)
IV 23 (20.00) 25 (14.71)
Unknown 1 (0.87) 0 (0.00)
Grade
GB 1 (0.87) 1 (0.59)
G2 8 (6.96) 25 (14.71)
G3 104 (90.43) 140 (82.35)
G4 0 (0.00) 1 (0.59)
Unknown 2 (1.74) 3 (1.76)
Venous invasion
NO 9 (7.83) 17 (10.00)
YES 17 (14.78) 24 (14.12)
Unknown 89 (77.39) 129 (75.88)
Lymphatic invasion
NO 9 (7.83) 19 (11.18)
YES 32 (27.83) 33 (19.41)
Unknown 74 (64.35) 118 (69.41)
Tumor residual disease
No macroscopic disease 11 (9.57) 27 (15.88)
1–10 mm 53 (46.09) 85 (50.00)
11–20 mm 8 (6.96) 12 (7.06)
>20 mm 32 (27.83) 25 (14.71)
Unknown 11 (9.57) 21 (12.35)

*Data are mean ± SD and frequency (percent) for numeric and category variables, respectively.